To confirm that these changes could be seen in human tumors, we performed immunohistochemistry on tumor tissue from two independent tumors from both ERMS and ARMS patients and found that ERMS tumors expressed higher EGR1 levels than ARMS tumors (Figure 1E). Here, EGR1 is linked to alveolar rhabdomyosarcoma.